secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sanara MedTech Inc. (SMTI)
CIK:        0000714256
Form:       8-K
Filed at:   2024-05-30T23:59:59+00:00
Accession:  0001493152-24-021982
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Sanara MedTech Inc. CEO Zachary B. Fleming Resigns, Enters Separation Agreement
-------------------------------------------------------------------------------

- Zachary B. Fleming resigned as CEO effective May 10, 2024; separation agreement signed May 29, 2024.
- Separation benefits include 12 months base salary paid in installments over 12 months.
- Company to pay COBRA premiums for Fleming and dependents during the severance period.
- 50% of unvested restricted stock continues to vest; partial acceleration for tax withholding.
- Fleming provides general release and non-disparagement covenant in exchange for benefits.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/714256/000149315224021982/0001493152-24-021982-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/714256/000149315224021982/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-021982

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer